ScholarIQanswers from OpenAlex

Belimumab for systemic lupus erythematosus – Focus on lupus nephritis

PaperCitations, authors & open-access status

Belimumab for systemic lupus erythematosus – Focus on lupus nephritis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Belimumab for systemic lupus erythematosus – Focus on lupus nephritis have?

ScholarIQcitation count

Belimumab for systemic lupus erythematosus – Focus on lupus nephritis has 31 citations in the OpenAlex counts ScholarIQ stores.

When was Belimumab for systemic lupus erythematosus – Focus on lupus nephritis published?

ScholarIQyear

Belimumab for systemic lupus erythematosus – Focus on lupus nephritis has 2022 year in the ScholarIQ index.

What is the open-access status of Belimumab for systemic lupus erythematosus – Focus on lupus nephritis?

ScholarIQoa status

Belimumab for systemic lupus erythematosus – Focus on lupus nephritis has gold oa status in the ScholarIQ index.

What is the DOI of Belimumab for systemic lupus erythematosus – Focus on lupus nephritis?

ScholarIQdoi

The DOI for Belimumab for systemic lupus erythematosus – Focus on lupus nephritis is on the source record.

What is the PMID of Belimumab for systemic lupus erythematosus – Focus on lupus nephritis?

ScholarIQpmid

The PMID for Belimumab for systemic lupus erythematosus – Focus on lupus nephritis is on the source record.

What is the OpenAlex record for Belimumab for systemic lupus erythematosus – Focus on lupus nephritis?

ScholarIQopenalex

The OpenAlex for Belimumab for systemic lupus erythematosus – Focus on lupus nephritis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial